Modulating the gut microbiota via dietary interventions is a common strategy to enhance the natural defence mechanisms of the host. Several in vitro studies have highlighted the probiotic potential of Bifidobacterium thermophilum RBL67 (RBL67) selected for its anti-Salmonella effects. The present study aimed to investigate the impact of RBL67 alone and combined with fructooligosaccharides (FOS) on the gut microbiota of Göttingen minipigs. Minipigs were fed a basal diet supplemented with 8 g/d probiotic powder (1 × 10 9 CFU/g in skim milk matrix) (probiotic diet (PRO)), 8 g/d probiotic powder plus 8 g/d FOS (synbiotic diet (SYN)) or 8 g/d skim milk powder (control), following a cross-sectional study design. Faecal and caecal microbiota compositions were analysed with pyrosequencing of 16S rRNA genes and quantitative PCR. Metabolic activity in the caecum and colon was measured by HPLC. 16S rRNA gene amplicon sequencing revealed that minipig faeces show close similarity to pig microbiota. During the treatments and at the time of killing of animals, RBL67 was consistently detected in faeces, caecum and colon at numbers of 10 5 -10 6 16S rRNA copies/g content after feeding PRO and SYN diets. At the time of killing of animals, significantly higher Bifidobacterium numbers in the caecum and colon of SYN-fed minipigs were measured compared with PRO. Our data indicate that the Göttingen minipig may be a suitable model for gut microbiota research in pigs. Data from this first in vivo study of RBL67 colonisation suggest that the combination with FOS may represent a valuable symbiotic strategy to increase probiotic bacteria levels and survival in gastrointestinal tracts for feed and food applications.Key words: Probiotics: Synbiotics: Gut microbiota modulation: In vivo studies: Animal modelsThe gut microbiota provides a beneficial barrier function for the host, especially against common enteropathogens such as Salmonella or Escherichia coli that are encountered in pig farms. This barrier effect is possibly enhanced by probiotic bacteria that contribute to gut microbiota modulation. Specific characteristics attributed to probiotics include competition for nutrients and adhesion sites, stimulation of SCFA, production of antimicrobial substances and modulation of the immune response (1,2) . Probiotic traits are strain-specific, and must therefore be proven for any given strain. With safe history of use, strains of the genera Bifidobacterium and Lactobacillus are widely represented among probiotics (2) . Bifidobacterium thermophilum strains have been primarily isolated from the bovine rumen and animal faeces, mainly calf and pig (3,4) , and have also been found in the faeces of babies (5,6) . The probiotic potential of the human faecal isolate B. thermophilum RBL67 (RBL67) was investigated in several in vitro studies. Strain RBL67 produces a bacteriocin-like substance (5,7) , adheres to human intestinal cell lines (8) and exhibits protective effects on epithelial integrity in the presence of a competing human microbiota (9) . Fu...